Creating a biorepository for studying inflammatory skin disorders
The Ohio State University Dermatology Biorepository
This study is trying to collect and analyze samples from people with and without inflammatory skin disorders to better understand these conditions and help find new treatments.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 175 (estimated) |
| Sex | All |
| Sponsor | Ohio State University Academic / other |
| Locations | 1 site (Columbus, Ohio) |
| Trial ID | NCT03146676 on ClinicalTrials.gov |
What this trial studies
This observational study aims to establish a biorepository of clinical specimens, including blood, skin tissue, and swab samples, from patients with and without inflammatory skin disorders. Utilizing various molecular techniques such as flow cytometry, PCR, histology, and immunohistochemistry, the study will analyze these samples to better understand the mechanisms behind conditions like Hidradenitis Suppurativa. The goal is to facilitate future translational research that could lead to insights into disease mechanisms and potential genetic mutations. By building this tissue bank, the study seeks to enhance our understanding of the biology and natural history of skin diseases.
Who should consider this trial
Good fit: Ideal candidates include individuals seen by an Ohio State University Dermatology provider who are willing to provide informed consent.
Not a fit: Patients who are unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and treatment options for patients with inflammatory skin disorders.
How similar studies have performed: While this approach is not novel, similar studies have successfully established biorepositories that have advanced research in inflammatory skin disorders.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Seen by an Ohio State University (OSU) Dermatology provider on the main University Hospital campus, including the James Cancer Hospital, OSU Dermatology East, OSU Dermatology at the Ohio State Eye and Ear Institute, Martha Morehouse Medical Pavilion, and OSU Dermatology at Upper Arlington after the date of approval of this protocol * Ability to provide informed consent, or parent or legal guardian capable of providing consent for child or mentally handicapped individuals * Willingness to participate in a research study. Exclusion Criteria: * Inability to provide informed consent
Where this trial is running
Columbus, Ohio
- OSU Dermatology West — Columbus, Ohio, United States (Recruiting)
Study contacts
- Principal investigator: Benjamin Kaffenberger, MD — Dermatologist
- Study coordinator: Alison Rocchi
- Email: alison.wandling@osumc.edu
- Phone: 614-685-0251
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.